
One of the greatest challenges in biomedical research isn't making a discovery—it's turning that discovery into something that improves patients' lives. The path from a promising scientific breakthrough to a new therapy is long, complex, and often filled with obstacles. That's why translational research and strong industry partnerships have become so critical to advancing innovation.
Today's guest is Dr. Alan Palkowitz, President and CEO of the Indiana Biosciences Research Institute, or IBRI. Alan is a veteran pharmaceutical R&D leader with decades of experience in drug discovery, translational science, and therapeutic development. Throughout his career, he has helped advance innovative therapies and led teams focused on transforming scientific insights into real-world impact.
More episodes from "BioSignals"



Don't miss an episode of “BioSignals” and subscribe to it in the GetPodcast app.








